This sEV-driven mechanism not only allows AML cells to avoid death, presumably by packaging drugs into vesicles, but it promotes expansion of cholesterol-enriched chemoresistant AML cells which, in turn, promote further release of HMGCR (+) sEVs. This evidence concerns the gene HMGCR and acute myeloid leukemia.